...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
AGORACOM NEWS FLASH
BREAKING: TransCanna Receives State-Wide Operating License
- Now owns largest known fully licensed cannabis facilities in California
- Successfully granted a Type 11 'Distributor' license by the California Bureau of Cannabis Control for its 196,000 square foot Daly Avenue Facility
- This long-anticipated milestone marks the completion of all state and local licenses required for the Company to begin operations at its flagship cannabis processing facility in Modesto, California
Hub On AGORACOM / Read Release
Due Dilligence
BETonMACE Cognitive Assessment Results Corporate Webcast Slides
Posted by:
BearDownAZ
on
Dec 06, 2019 07:41PM
Resverlogix Corp. Links
NEJM BETonMACE Editorial - Epigenetic Therapeutics for Cardiovascular Disease Writing, Erasing, Reading, and Maybe Forgetting
Posted by:
BearDownAZ
on
Mar 31, 2020 08:21AM
NEJM BETonMACE Publication - Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial
Posted by:
BearDownAZ
on
Mar 31, 2020 08:20AM
The BET Protein Inhibitor Apabetalone Reduces Congestive Heart Failure Incidence in Patients with Acute Coronary Syndrome and Diabetes: Results from the BETonMACE Trial - ACC/WCC 2020 Poster
Posted by:
BearDownAZ
on
Mar 31, 2020 08:18AM
Epigenetic Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Hyperactivation of CD14+ Monocytes from Patients with Type 2 Diabetes and Cardiovascular Disease - ACC/WCC 2020 Poster
Posted by:
BearDownAZ
on
Mar 31, 2020 08:18AM
Epigenetics in CVD: A collection of PACE-CME symposium presentations
Posted by:
BearDownAZ
on
Feb 11, 2020 10:52AM